# Genworth Financial Inc: overview

GNW · NYSE · CIK 1276520 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/gnw.md) · [Financials](/companies/gnw/financials.md) · [Filings](/companies/gnw/filings.md) · [Insiders](/companies/gnw/insiders.md)

Latest reported revenue: [$1.90bn](/filings/0001628280-26-054344.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 6, 2026 (XBRL us-gaap:Revenues, accession 0001628280-26-054344).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,880](/filings/0001628280-25-050196.md) | [1,782 d](/filings/0001628280-26-012828.md) | [1,786](/filings/0001628280-26-031374.md) | [1,796](/filings/0001628280-26-054344.md) | [1,935](/filings/0001628280-25-050196.md) | [1,784 d](/filings/0001628280-26-012828.md) | [1,777](/filings/0001628280-26-031374.md) | [1,901](/filings/0001628280-26-054344.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [2.6%](/filings/0001193125-24-253279.md) | not reported | [2.9%](/filings/0001193125-25-110536.md) | [3.8%](/filings/0001193125-25-170565.md) | not reported | not reported | not reported | not reported |
| Net margin | % | [4.5%](/filings/0001628280-25-050196.md) | [(0.1%) d](/filings/0001628280-26-012828.md) | [3.0%](/filings/0001628280-26-031374.md) | [2.8%](/filings/0001628280-26-054344.md) | [6.0%](/filings/0001628280-25-050196.md) | [0.1% d](/filings/0001628280-26-012828.md) | [2.6%](/filings/0001628280-26-031374.md) | [2.5%](/filings/0001628280-26-054344.md) |
| Diluted EPS | $ per share | [0.19](/filings/0001628280-25-050196.md) | not reported | [0.13](/filings/0001628280-26-031374.md) | [0.12](/filings/0001628280-26-054344.md) | [0.28](/filings/0001628280-25-050196.md) | not reported | [0.12](/filings/0001628280-26-031374.md) | [0.12](/filings/0001628280-26-054344.md) |
| Free cash flow | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [7,822](/filings/0001193125-24-051772.md) | [7,495](/filings/0001193125-25-041860.md) | [7,488](/filings/0001628280-26-012828.md) | [7,295](/filings/0001628280-26-012828.md) | [7,301](/filings/0001628280-26-012828.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [6.1%](/filings/0001193125-24-051772.md) | [10.9%](/filings/0001193125-24-051772.md) | [0.5%](/filings/0001193125-24-051772.md) | not reported | not reported |
| Net margin | % | [10.9%](/filings/0001193125-24-051772.md) | [12.2%](/filings/0001193125-25-041860.md) | [1.0%](/filings/0001628280-26-012828.md) | [4.1%](/filings/0001628280-26-012828.md) | [3.1%](/filings/0001628280-26-012828.md) |
| Diluted EPS | $ per share | [1.65](/filings/0001193125-24-051772.md) | [1.79](/filings/0001193125-25-041860.md) | [0.16](/filings/0001628280-26-012828.md) | [0.68](/filings/0001628280-26-012828.md) | [0.54](/filings/0001628280-26-012828.md) |
| Free cash flow | $m | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/gnw/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $529.2m | 55,882,496 |  | Reduced −1,003,900 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $242.6m | 25,621,860 |  | Added +109,871 |
| [DONALD SMITH & CO., INC.](/funds/814375.md) | 2026-06-30 | $212.9m | 22,482,191 |  | Reduced −3,004,112 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $210.3m | 22,201,926 |  | Reduced −1,211,698 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $157.3m | 16,605,783 |  | Reduced −1,174,245 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $156.7m | 16,548,421 |  | Added +28,089 |
| [River Road Asset Management, LLC](/funds/1341401.md) | 2026-06-30 | $137.0m | 14,472,015 |  | Reduced −849,597 |
| [AMERICAN CENTURY COMPANIES INC](/funds/748054.md) | 2026-06-30 | $109.3m | 11,540,602 |  | Added +453,314 |
| [Nuveen, LLC](/funds/1871926.md) | 2026-06-30 | $105.9m | 11,184,305 |  | Added +1,103,097 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $96.9m | 10,232,701 |  | Added +276,451 |

## Recent filings

[All 1,814 filings](/companies/gnw/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-30 | 07:15 ET | [8-K](/filings/0001276520-26-000047.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001276520-26-000047 |
| 2026-10-13 | 16:15 ET | [8-K](/filings/0001276520-26-000043.md) | 5.02 Departure or appointment of officers or directors | 0001276520-26-000043 |
| 2026-08-20 | 16:15 ET | [8-K](/filings/0001276520-26-000041.md) | 5.02 Departure or appointment of officers or directors | 0001276520-26-000041 |
| 2026-08-06 | 16:18 ET | [10-Q](/filings/0001628280-26-054344.md) | Quarterly report, period 2026-06-30 | 0001628280-26-054344 |
| 2026-08-05 | 16:18 ET | [8-K](/filings/0001628280-26-053389.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-053389 |
| 2026-07-07 | 16:10 ET | [8-K](/filings/0001276520-26-000032.md) | 5.02 Departure or appointment of officers or directors | 0001276520-26-000032 |
| 2026-05-21 | 16:15 ET | [8-K](/filings/0001276520-26-000029.md) | 5.07 Shareholder vote results | 0001276520-26-000029 |
| 2026-05-06 | 16:39 ET | [10-Q](/filings/0001628280-26-031374.md) | Quarterly report, period 2026-03-31 | 0001628280-26-031374 |
| 2026-05-05 | 16:18 ET | [8-K](/filings/0001628280-26-030585.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-030585 |
| 2026-02-27 | 16:17 ET | [10-K](/filings/0001628280-26-012828.md) | Annual report, period 2025-12-31 | 0001628280-26-012828 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001628280-26-012828.md), filed Feb 27, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/908d00d9-cdde-428b-a353-298d8cea70a1)

## About the filer

- CIK: 1276520
- Tickers: GNW
- Exchange: NYSE
- SIC code: 6311 Life Insurance
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 07:16 ET. No prices; not investment advice.